Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Takeshi Arita is active.

Publication


Featured researches published by Takeshi Arita.


Circulation-cardiovascular Interventions | 2010

Very Long-Term (15 to 20 Years) Clinical and Angiographic Outcome After Coronary Bare Metal Stent Implantation

Kyohei Yamaji; Takeshi Kimura; Takeshi Morimoto; Yoshihisa Nakagawa; Katsumi Inoue; Yoshimitsu Soga; Takeshi Arita; Shinichi Shirai; Kenji Ando; Katsuhiro Kondo; Koyu Sakai; Masahiko Goya; Masashi Iwabuchi; Hiroyoshi Yokoi; Hideyuki Nosaka; Masakiyo Nobuyoshi

Background—We previously reported that the long-term luminal response after coronary bare metal stenting is triphasic, with an early restenosis phase spanning the 6 months after the index procedure, an intermediate-term regression phase from 6 months to 3 years, and a late renarrowing phase beyond 4 years. However, the clinical significance of late luminal renarrowing remains unknown. Methods and Results—Angiographic and clinical follow-up of the same cohort of 405 patients with successful Palmaz-Schatz stent placement was extended beyond 15 years. Clinical follow-up was completed in 98% of patients at 5 years and in 81% at 15 years. The incidence of death and cardiac death at 15 years was 45.4% and 20.6%, respectively. Paired long-term (4 to 10 years) and very long-term (>10 years) angiographic studies without intercurrent target lesion revascularization were performed in 55 lesions, and minimal luminal diameter further decreased from 1.88±0.50 mm to 1.60±0.73 mm (P=0.002). Late target lesion revascularization after initial stabilization of the stented segments occurred rarely within 4 years. Beyond 4 years, however, the incidence of late target lesion revascularization increased steadily from 3.3% at 4 years to 24.7% at 15 years. The incidence of definite very late stent thrombosis was low (1.5% at 15 years). Conclusions—Luminal renarrowing of the stented segment beyond 4 years was a progressive process extending beyond 10 years. The angiographic observation of late in-stent restenosis was clinically relevant because a corresponding progressive increase in the incidence of late target lesion revascularization was observed beyond 4 years and up to 15 to 20 years after bare metal stent implantation.


Circulation | 2009

Percutaneous Balloon Mitral Valvuloplasty A Review

Masakiyo Nobuyoshi; Takeshi Arita; Shin ichi Shirai; Naoya Hamasaki; Hiroyoshi Yokoi; Masashi Iwabuchi; Hitoshi Yasumoto; Hideyuki Nosaka

Several diseases have been acknowledged as pathological causes for mitral valve stenosis (MS), of which rheumatic heart disease is the most prevalent. Rheumatic heart disease is a chronic manifestation of rheumatic carditis, which occurs in 60% to 90% of cases of rheumatic fever. Rheumatic fever is a late sequela to Group A β-hemolytic streptococcal infection of the throat. The initial rheumatic fever results only in an edematous inflammatory process, leading to the fibrinoid necrosis of the connective tissue and cellular reactions. The initial valvulitis results in verruciform deposition of fibrin along the closing portion of the leaflets. Although all of the cardiac valves may be involved by this rheumatic process, the mitral valve is involved most prominently. The endocardial lesion most often leaves permanent sequela resulting in valvular regurgitation, stenosis, or both. Stenosis of this valve occurs from leaflet thickening, commissural fusion, and chordal shortening/fusion due to the above described pathological process.nnThe decrease of the incidence of rheumatic heart disease in developed countries had already begun in 1910, and it is now below 1.0 per 100 000. On the other hand, the occurrence rate of rheumatic heart disease in developing countries remains substantial. Because the decline in the prevalence of rheumatic fever in industrialized nations started even before the era of penicillin and thus was related to improved living standards, the continued prevalence of rheumatic heart disease in undeveloped or developing countries is related not only to the limited availability of penicillin but to their socioeconomic status (ie, overpopulation, overcrowding, poverty, and poor access to medical care).nnAccording to the annual report by the World Heart Federation, an estimated 12 million people are currently affected by rheumatic fever and rheumatic heart disease worldwide, and high incidence rates are reported in the Southern Pacific Islands. Several studies were conducted on …


Circulation-cardiovascular Interventions | 2012

Incidence and Clinical Impact of Stent Fracture After Everolimus-Eluting Stent Implantation

Shoichi Kuramitsu; Masashi Iwabuchi; Takuya Haraguchi; Takenori Domei; Ayumu Nagae; Makoto Hyodo; Kyohei Yamaji; Yoshimitsu Soga; Takeshi Arita; Shinichi Shirai; Katsuhiro Kondo; Kenji Ando; Koyu Sakai; Masahiko Goya; Yoshitaka Takabatake; Shinjo Sonoda; Hiroyoshi Yokoi; Fumitoshi Toyota; Hideyuki Nosaka; Masakiyo Nobuyoshi

Background—Stent fracture (SF) after drug-eluting stent implantation has recently become an important concern because of its potential association with in-stent restenosis and stent thrombosis. However, the incidence and clinical impact of SF after everolimus-eluting stent implantation remain unclear. Methods and Results—A total of 1035 patients with 1339 lesions undergoing everolimus-eluting stent implantation and follow-up angiography 6 to 9 months after index procedure were analyzed. SF was defined as complete or partial separation of the stent, as assessed by plain fluoroscopy or intravascular ultrasound during follow-up. We assessed the rates of SF and major adverse cardiac events, defined as cardiac death, myocardial infarction, stent thrombosis, and clinically driven target lesion revascularization within 9 months. SF was observed in 39 of 1339 lesions (2.9%) and in 39 of 1035 patients (3.8%). Ostial stent location and lesions with hinge motion, tortuosity, or calcification were independent predictors of SF. The rate of myocardial infarction and target lesion revascularization were significantly higher in the SF group than in the non-SF group (5.1% versus 0.4%; P=0.018 and 25.6% versus 2.0%; P<0.001, respectively). Stent thrombosis was more frequently observed in the SF group than in the non-SF group (5.1% versus 0.4%; P=0.018). Major adverse cardiac events within 9 months were significantly higher in the SF group than in the non-SF group (25.6% versus 2.3%; P<0.001). Conclusions—SF after everolimus-eluting stent implantation occurs in 2.9% of lesions and is associated with higher rate of major adverse cardiac events, driven by higher target lesion revascularization and stent thrombosis.


Jacc-cardiovascular Interventions | 2010

Impact of multiple and long sirolimus-eluting stent implantation on 3-year clinical outcomes in the j-Cypher Registry.

Shinichi Shirai; Takeshi Kimura; Masakiyo Nobuyoshi; Takeshi Morimoto; Kenji Ando; Yoshimitsu Soga; Kyohei Yamaji; Katsuhiro Kondo; Koyu Sakai; Takeshi Arita; Masahiko Goya; Masashi Iwabuchi; Hiroyoshi Yokoi; Hideyuki Nosaka; Kazuaki Mitsudo; j-Cypher Registry Investigators

OBJECTIVESnOur aim was to study the relationships between total stent length (TSL) and long-term clinical outcomes after sirolimus-eluting stent (SES) implantation.nnnBACKGROUNDnSES compared with bare-metal stent use for long lesion treatment is associated with reduced restenosis rates.nnnMETHODSnThree-year follow-up data were available for 10,773 patients (14,651 lesions) that had been treated with only SES (Cypher, Cordis Corp., Warren, New Jersey) in the j-Cypher registry. Patients and lesions were divided into quartile groups: TSL per patient (Q1: 8 to 23 mm, Q2: 24 to 36 mm, Q3: 37 to 54 mm, Q4: 55 to 293 mm), and TSL per lesion (QA: 8 to 18 mm, QB: 19 to 23 mm, QC: 24 to 33 mm, QD: 34 to 150 mm).nnnRESULTSnIn per-lesion data, longer TSL increased target lesion revascularization (TLR) rates but did not increase stent thrombosis rates (p = 0.2324). In per-patient data, the incidences of TLR remarkably increased with increasing TSL. Incidence of composite of death and myocardial infarction also increased with increasing TSL; however, after adjustment for baseline differences, there was no statistical significance. Definite stent thrombosis rate in group Q4 was significantly higher than in other groups, both unadjusted (hazard ratio: 1.770, p = 0.0081) and adjusted (hazard ratio: 1.727, p = 0.0122) for baseline differences.nnnCONCLUSIONSnTSL per lesion and patient had significantly impacts on TLR rates. Longer TSL per patient was associated with increased incidence of stent thrombosis through 3 years.


Cardiovascular Diabetology | 2013

Impact of post-challenge hyperglycemia on clinical outcomes in japanese patients with stable angina undergoing percutaneous coronary intervention

Shoichi Kuramitsu; Hiroyoshi Yokoi; Takenori Domei; Akihiro Nomura; Hirotoshi Watanabe; Kyohei Yamaji; Yoshimitsu Soga; Takeshi Arita; Katsuhiro Kondo; Shinichi Shirai; Kenji Ando; Koyu Sakai; Masashi Iwabuchi; Hedeyuki Nosaka; Masakiyo Nobuyoshi

BackgroundPost-challenge hyperglycemia (PH) is well-established as one of risk factors for coronary artery disease. However, it remains unclear whether PH affects clinical outcomes in patients with stable angina undergoing percutaneous coronary intervention (PCI).MethodsA total of 828 patients with stable angina undergoing PCI were retrospectively analyzed. Of these, 452 patients with previously diagnosed diabetes mellitus (DM) or fasting plasma glucose (PG) ≥126 mg/dl and HbA1c ≥6.5% were defined as known DM. The remaining 376 patients were divided into the two groups according to 2-h PG: PH (2-h PG ≥140 mg/dl, n=236) and normal glucose tolerance (NGT, 2-h PG <140 mg/dl, n=140). We assessed the rate of major adverse cardiovascular events (MACE), defined as a composite of cardiovascular death, myocardial infarction, stroke, and clinically-driven revascularization.ResultsDuring the median follow-up of 4.3 years, the MACE rate was significantly higher in the DM and PH groups than the NGT group (39.3% vs. 20.7%, P <0.001; 31.4% vs. 20.7%, P=0.044, respectively). Compared with the NGT group, the cumulative incidence of revascularization was significantly higher in the DM group (35.1% vs. 18.5%, P <0.001) and tended to be higher in the PH group (27.1% vs. 18.5%, P=0.067). In the multivariate analysis, known DM (Hazard ratio [HR]: 2.16, 95% confidence interval (CI): 1.49-3.27, P < 0.001), PH (HR: 1.62, 95% CI: 1.07-2.53, P = 0.023), LDL-C >100 mg/dl (HR: 1.62, 95% CI: 1.26 to 2.10, P < 0.001), and previous stroke (HR: 1.47, 95% CI: 1.03-2.04, P = 0.034) were predictors of MACE.ConclusionPH is associated with future cardiovascular events in patients with stable angina undergoing PCI.


Journal of the American Heart Association | 2012

Very Long-Term (15 to 23 Years) Outcomes of Successful Balloon Angioplasty Compared With Bare Metal Coronary Stenting

Kyohei Yamaji; Takeshi Kimura; Takeshi Morimoto; Yoshihisa Nakagawa; Katsumi Inoue; Shoichi Kuramitsu; Yoshimitsu Soga; Takeshi Arita; Shinichi Shirai; Kenji Ando; Katsuhiro Kondo; Koyu Sakai; Masashi Iwabuchi; Hiroyoshi Yokoi; Hideyuki Nosaka; Masakiyo Nobuyoshi

Background Target lesion revascularization (TLR) continues to occur beyond 4 years after bare metal stent (BMS) implantation. However, long-term outcomes after balloon angioplasty (BA) compared with BMS are currently unknown. Methods and Results From 1989 to 1990, 659 patients (748 lesions) underwent successful BA with final balloon ≥3.0 mm excluding patients with acute myocardial infarction and were compared with 405 patients (424 lesions) with BMS implantation from June 1990 to 1993. Cumulative incidences of death and target lesion thrombosis (>1 year) were similar between the BA group and the BMS group (44.4% versus 45.4%, P=0.60; and 1.5% versus 0.7%, P=0.99; respectively). Cumulative incidence of TLR during overall follow-up was significantly higher after BA than after BMS implantation (44.6% versus 36.0%, P<0.001), whereas cumulative incidence of late TLR (>4 years) tended to be lower in the BA group than in the BMS group (16.3% versus 21.4%, P=0.16). Cumulative incidence of late TLR after BA was significantly lower in patients with small percent diameter stenosis (%DS) at early follow-up angiography compared with large %DS (14.5% versus 28.0%, P=0.02). In lesions with serial angiography, late lumen loss from early (6 to 14 months) to long-term (4 to 10 years) follow-up angiography was significantly smaller in the BA group (n=42) than in the BMS group (n=55) (−0.08±0.45 mm versus 0.11±0.46 mm, P=0.047). Conclusions Compared with BMS implantation, BA was associated with a trend for less late TLR beyond 4 years and with significantly smaller late lumen loss from early to long-term follow-up angiography.


International Journal of Cardiology | 2017

Duration of reverse remodeling response to cardiac resynchronization therapy: Rates, predictors, and clinical outcomes

Takafumi Oka; Koichi Inoue; Koji Tanaka; Yuko Toyoshima; Takaaki Isshiki; Takeshi Kimura; Masakiyo Nobuyoshi; Satoshi Shizuta; Takeshi Arita; Satoki Fujii; Katsuomi Iwakura; Kenshi Fujii; Kenji Ando

BACKGROUNDnA subset of patients undergoing cardiac resynchronization therapy (CRT) for heart failure (HF) with severe left ventricular (LV) dysfunction experience only short-lived LV reverse remodeling. Little is known about the incidence and prognosis of this finding. We sought to identify predictors of a brief response and investigated the prognosis in a retrospective study.nnnMETHODSnA total of 528 patients from a Japanese multicenter database with full echocardiography datasets were enrolled. Follow-up was 3.4±1.3years. Based on relative reduction in LV end-systolic volume (LVESV) at 6months, we categorized patients as responders (reduction in LVESV ≥15%) and non-responders (NRs; reduction in LVESV <15%). Based on reduction in LVESV at 1-2years, responders were subdivided into long-lasting responders (reduction in LVESV ≥15%) and brief responders (reduction in LVESV <15%).nnnRESULTSnOf 328 responders, 50 (15%) were brief responders. Predictors of brief response were prior ventricular tachyarrhythmia, a non-left bundle-branch block (LBBB) intrinsic QRS pattern, and prior hospitalization for HF. The risk of all-cause death in brief responders was significantly lower than that in NRs (P=0.034) and tended to be higher than that in long-lasting responders (P=0.080).nnnCONCLUSIONSnApproximately 15% of responders were brief responders. Prior ventricular tachyarrhythmia, a non-LBBB pattern, and HF hospitalization were independent predictors of a brief response. Brief response was significantly associated with decreased risk of all-cause death compared with NRs and had a tendency toward increased risk of all-cause death compared with long-lasting responders.


Eurointervention | 2012

Very long-term outcomes after percutaneous coronary intervention with bare metal stents for unprotected left main coronary artery disease.

Akihiro Nomura; Kyohei Yamaji; Shinichi Shirai; Fumio Omata; Yoshimitsu Soga; Michio Nagashima; Takeshi Arita; Kenji Ando; Koyu Sakai; Masahiko Goya; Hiroyoshi Yokoi; Masashi Iwabuchi; Masakiyo Nobuyoshi

AIMSnThe aim of this study was to evaluate very long-term clinical outcomes and potential predictors after percutaneous coronary intervention (PCI) with bare metal stents (BMS) for unprotected left main coronary artery disease (ULMCAD).nnnMETHODS AND RESULTSnFrom March 1991 to August 2001, 151 patients who underwent PCI with BMS for ULMCAD were investigated retrospectively. The patient-oriented major adverse cardiac events (MACE) were defined as the occurrence of all-cause death, any MI, and any coronary revascularisation. The median follow-up duration was 10.5 years. The mean age was 69.9±11.5 years, and 106 patients (70.2%) were male. At 10 years, the incidences of cardiac death (CD), target lesion revascularisation (TLR) and patient-oriented MACE were 11.1%, 25.2% and 81.9%, respectively. In multivariate analysis, the pre-reference diameter of the left main trunk (LMT) was significantly associated with TLR (adjusted hazard ratio [HR] [95% confidence interval (CI)], 0.28 [0.14-0.54], p<0.001) and the SYNTAX score remained an independent predictor of patient-oriented MACE (adjusted HR [95% CI], 1.03 [1.007-1.05], p=0.009).nnnCONCLUSIONSnThe pre-reference diameter of LMT was significantly associated with TLR, and the SYNTAX score significantly predicted the risk of patient-oriented MACE at 10 years. BMS implantation for larger size of ULMCAD with a lower SYNTAX score was feasible for up to 10 years.


Circulation | 2018

Effect of QRS Morphology and Duration on Clinical Outcomes After Cardiac Resynchronization Therapy ― Analysis of Japanese Multicenter Registry ―

Takafumi Oka; Koichi Inoue; Koji Tanaka; Yuko Hirao; Takaaki Isshiki; Takeshi Kimura; Masakiyo Nobuyoshi; Satoshi Shizuta; Takeshi Arita; Satoki Fujii; Katsuomi Iwakura; Kenshi Fujii; Kenji Ando

BACKGROUNDnQRS duration (QRSd) and morphology are established response predictors of cardiac resynchronization therapy (CRT). However, evidence in Japanese populations is lacking.Methodsu2004andu2004Results:We retrospectively analyzed the Japanese multicenter CRT database. We divided patients according to their intrinsic QRSd and morphology, and assessed echocardiographic responses and clinical outcomes. The primary endpoint was a composite of all-cause death or hospitalization because of heart failure. A total of 510 patients were enrolled: 200 (39%) had left bundle branch block (LBBB) and QRSd ≥150 ms; 80 (16%) had LBBB (QRSd: 120-149 ms); 61 (12%) had non-LBBB (NLBBB) (QRSd: ≥150 ms); 54 (11%) had NLBBB (QRSd: 120-149 ms); 115 (23%), narrow (<120 ms). The proportion of echocardiographic responders was higher in LBBB (QRSd ≥150 ms) [74% vs. 51% vs. 38% vs. 52% vs. 50%, LBBB (QRSd ≥150 ms) vs. LBBB (QRSd 120-149 ms) vs. NLBBB (QRSd ≥150 ms) vs. NLBBB (QRSd 120-149 ms) vs. narrow, respectively, P<0.001]. During follow-up (3.2±1.5 years), the incidence of the primary endpoint was lowest in the LBBB group (QRSd ≥150) (28.6% vs. 42.3% vs. 45.9% vs. 55.6% vs. 55.3%, respectively, P<0.001). This difference was still significant after adjusting for other baseline characteristics.nnnCONCLUSIONSnIn this Japanese patient population, LBBB intrinsic QRS morphology and prolonged QRSd (≥150 ms) exhibited the best response to CRT.


Circulation-cardiovascular Interventions | 2013

Response to Letter Regarding Article, “Incidence and Clinical Impact of Stent Fracture After Everolimus-Eluting Stent Implantation”

Shoichi Kuramitsu; Masashi Iwabuchi; Takenori Domei; Makoto Hyodo; Kyohei Yamaji; Yoshimitsu Soga; Takeshi Arita; Shinichi Shirai; Katsuhiro Kondo; Kenji Ando; Koyu Sakai; Masahiko Goya; Hiroyoshi Yokoi; Hideyuki Nosaka; Masakiyo Nobuyoshi; Takuya Haraguchi; Ayumu Nagae; Yoshitaka Takabatake; Fumitoshi Toyota; Shinjo Sonoda

We thank Dr Paul D. Williams, Dr Mama A. Mamas, and Dr Douglas G. Fraser for their interest in our article.1 First, we investigated the stent fracture after Xience V (Abbott Vascular) and Promus (Boston Scientific). As they note, our results, therefore, do not apply to all everolimus-eluting stents.nnSecond, they suggest that double stent strut layer shown in Figure 4 is the consequence of stent fracture rather than longitudinal stent deformation. Actually, it may well be that there is considerable overlap between …

Collaboration


Dive into the Takeshi Arita's collaboration.

Top Co-Authors

Avatar

Masakiyo Nobuyoshi

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar

Kenji Ando

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar

Masashi Iwabuchi

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar

Hiroyoshi Yokoi

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar

Yoshimitsu Soga

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar

Masahiko Goya

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar

Shinichi Shirai

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Koyu Sakai

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar

Hideyuki Nosaka

Memorial Hospital of South Bend

View shared research outputs
Researchain Logo
Decentralizing Knowledge